Enovis has lowered its price target to $27 from $30 following its binding offer to acquire eCential Robotics for €155 million. This acquisition aims to strengthen Enovis's position in surgical robotics and enhance its ASTRA technology ecosystem. Despite the strategic move, Enovis's stock fell 16.5% to $20.53 on the day of the announcement. The deal reflects Enovis's long-term growth plan in advanced robotics technology.
Citigroup reaffirmed its Buy rating on NIO but lowered the price target from $8.20 to $7.10 due to NIO's second-quarter deliveries and revenue missing company guidance and a third-quarter outlook below Wall Street estimates. Despite a 49.4% year-over...
Yum! Brands recently sold its Pizza Hut division and CEO Christopher Lee Turner sold shares amid legal scrutiny. The company is under investigation by Pomerantz LLP for possible securities fraud following a food safety crisis linked to a cyclosporias...
Dell Technologies reported quarterly revenue of $46.97 billion and earnings per share of $7.04, both surpassing analyst expectations. The company's growth is fueled by strong demand in its AI server business, supported by a substantial $51 billion or...
Analyst BTIG upgraded Medtronic to a Buy rating and raised its price target to $100, citing strong Q1 FY2027 revenue of $9.76 billion driven by broad demand. The company is investing over $700 million in Heart Tech and Robotics, signaling a focus on ...
Regis Corporation reported a strong Q4 2026 with earnings per share of $1.04, far exceeding analyst expectations of $0.17. The company generated $56 million in revenue, slightly down year-over-year but above estimates, supported by a 2.6% sales rise ...
